Launching the Alzheimer’s Disease Atlas at ADI2026 Conference
On 15 April, at the ADI Conference in Lyon, France, ADI shared the Alzheimer’s Disease Atlas, a first-of-its-kind website mapping the global landscape of Alzheimer’s disease.
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
On 15 April, at the ADI Conference in Lyon, France, ADI shared the Alzheimer’s Disease Atlas, a first-of-its-kind website mapping the global landscape of Alzheimer’s disease.
Read the transcript of ADI CEO Paola Barbarino's full speech at the French Ministry of Health, in Paris, France, 10 April 2026.
Meera Pattabiraman, Chair of Alzheimer’s Disease and Related Disorders Society of India (ARDSI), writes about ARDSI’s successful engagements with the Ministry of Health and Family Welfare in India, a country where over 5 million people live with dementia.
Featured in the World Alzheimer Report 2019: Attitudes to dementia, Rangimahora Reddy and Pare Meha of the Rauawaawa Kaumātua Charitable Trust, as well as Dr Etuini Ma’u of the Waikato District Health Board and Professor John Oetzel of the University of Waikato, delve into the complexities surrounding diagnosing mate wareware (dementia) in Māori communities and how tailored cultural programmes can aid in supporting the individual and their whānau (family).
In this case study excerpt for the World Alzheimer Report 2019, Maree McCabe, CEO of Dementia Australia, writes about the importance of culturally sensitive diagnostic methods when addressing dementia within Indigenous Australian communities.
In this case study excerpt for the World Alzheimer Report 2019, María Cecilia López Murga, Executive of Asociación Group Ermita Alzheimer de Guatemala, writes about how the association's mission to address the challenges around dementia within Guatemala’s Indigenous communities.
In this case study excerpt for the World Alzheimer Report 2019, Kristen Jacklin and Karen Pitawanakwat write about understanding the experiences of dementia within Indigenous communities in order to meet dementia care needs in a culturally sensitive way.
In 2016 Spominčica – Alzheimer Slovenija started developing the Dementia Friendly Spots (DFS) programme. It is a national education and awareness-raising programme connecting a wide spectrum of organisations in a network of sites providing information about dementia locally. The network of DFS include: police and fire stations, shops, libraries,…
hinese Pharmaceutical Company Green Valley announces their drug Oligomannate (GV-971) has been granted conditional approval for the treatment of "mild to moderate Alzheimer's disease".
This piece questioning how we see and understand dementia friendly communities, their role and how they may evolve was contributed to the World Alzheimer Report 2019 by Glenn Rees, former Chair of ADI, and Dr Linda Barclay, a Senior Lecturer in Philosophy at Monash University who specialises in disability and justice.